191 related articles for article (PubMed ID: 3296954)
1. [Present status of studies on the application of immunology to the diagnosis and therapy of cancer, with emphasis on monoclonal antibodies and cytokines].
Tokunaga T
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1358-66. PubMed ID: 3296954
[TBL] [Abstract][Full Text] [Related]
2. Biological Response Modifiers Programme and cancer chemotherapy.
Oldham RK
Int J Tissue React; 1982; 4(3):173-88. PubMed ID: 6183193
[TBL] [Abstract][Full Text] [Related]
3. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
4. Biologicals and biological response modifiers: fourth modality of cancer treatment.
Oldham RK
Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Biological response modifiers.
Oldham RK
J Natl Cancer Inst; 1983 May; 70(5):789-96. PubMed ID: 6188871
[TBL] [Abstract][Full Text] [Related]
7. [Current possibilities in immunotherapy of cancer].
von Fliedner V
Schweiz Med Wochenschr; 1987 Feb; 117(7):243-8. PubMed ID: 3551061
[TBL] [Abstract][Full Text] [Related]
8. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
Shen RN; Lu L; Kaiser HE; Broxmeyer HE
In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
[TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
10. Bi-specific antibody therapy for the treatment of cancer.
Withoff S; Helfrich W; de Leij LF; Molema G
Curr Opin Mol Ther; 2001 Feb; 3(1):53-62. PubMed ID: 11249732
[TBL] [Abstract][Full Text] [Related]
11. Review: advances in monoclonal antibody tumour targeting.
Kosmas C; Linardou H; Epenetos AA
J Drug Target; 1993; 1(2):81-91. PubMed ID: 8069556
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy in head and neck cancer: current practice and future possibilities.
Agada FO; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunogene therapy.
Yoshizawa H; Kagamu H; Gejyo F
Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
[TBL] [Abstract][Full Text] [Related]
14. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
Khawli LA; Hu P; Epstein AL
Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody treatment of colorectal cancer.
Pullyblank AM; Monson JR
Br J Surg; 1997 Nov; 84(11):1511-7. PubMed ID: 9393269
[TBL] [Abstract][Full Text] [Related]
16. Recombinant toxins for the treatment of cancer.
Kreitman RJ
Curr Opin Mol Ther; 2003 Feb; 5(1):44-51. PubMed ID: 12669470
[TBL] [Abstract][Full Text] [Related]
17. Cancer treatment: what's ahead?
Parvez T
J Coll Physicians Surg Pak; 2005 Nov; 15(11):738-45. PubMed ID: 16300718
[TBL] [Abstract][Full Text] [Related]
18. [Antitumor immunotherapy].
Błoński JZ; Warzocha K
Postepy Hig Med Dosw; 1994; 48(6):701-28. PubMed ID: 7675731
[TBL] [Abstract][Full Text] [Related]
19. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y
Anticancer Res; 2006; 26(2A):1113-34. PubMed ID: 16619514
[TBL] [Abstract][Full Text] [Related]
20. Symposium on diagnosis and treatment of cancer. Recent progress.
Jpn J Med; 1988 Feb; 27(1):96-112. PubMed ID: 2452911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
